Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Gentian Diagnostics ASA
ASA
Active
Org 983860516
Bjørnåsveien 5, 1596
Moss
Technical testing and analysis
·
NACE 7120
Est. 2001 · 24 years old
2 employees
www.gentian.no
Monitor
Share
Norway
/
Companies
/
Technical testing and analysis
/
Gentian Diagnostics ASA
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 2M
2M
2021
2022: 4M (+100% vs 2021)
4M
+100%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 2M
2M
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
0M
-5M
-9M
-14M
-19M
2021: -13M
-13M
2021
2022: -11M (+15% vs 2021)
-11M
+15%
2022
2023: -15M (-36% vs 2022)
-15M
-36%
2023
2024: -10M (+33% vs 2023)
-10M
+33%
2024
2025: -14M (-40% vs 2024)
-14M
-40%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
2 245
1 604
0
4 040
2 456
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−14 043
−10 168
−14 544
−10 955
−13 475
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−14 043
−10 168
−14 544
−10 955
−13 475
Net financials
3 520
6 761
6 018
3 465
632
Profit before tax
−10 523
−3 407
−8 526
−7 490
−12 843
Tax
−0
−0
−0
−0
−0
Net profit
−10 523
−3 407
−8 526
−7 490
−12 843
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
254 187
260 391
262 525
269 370
273 877
Equity
241 156
251 813
260 397
266 329
272 076
Long-term debt
0
0
0
0
0
Short-term debt
13 031
8 578
2 128
3 041
1 800
Total debt
13 031
8 578
2 128
3 041
1 800
Financial ratios
5-year trend
EBITDA margin
−625,5 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
94,9 %
This company
38,2 %
Market median
This company
Market median
148% above market
2021
2025
Return on equity
−4,4 %
This company
18,4 %
Market median
This company
Market median
124% below market
2021
2025
Net profit margin
−468,7 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,01×
This company
1,12×
Market median
This company
Market median
99% below market
2021
2025
Debt / equity
0,05×
This company
0,62×
Market median
This company
Market median
92% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Gentian Diagnostics ASA
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
